Hallmarks of primary headache: part 1 – migraine

Признаки первичной головной боли: часть 1 — мигрень
Matilde Leonardi, Tissa Wijeratne, Tsubasa Takizawa, Marco A. Arruda, Valeria Caponnetto, Andreas Straube, Massimiliano Valeriani, Mário Fernando Prieto Peres, Paolo Martelletti, Sebastian Straube, Bianca Raffaelli, Kristin Sophie Lange, David García‐Azorín, Yonggang Wang, Fu‐Jung Hsiao, Igor Petrušić, Alejandro Labastida‐Ramírez, Dilara Onan, Claudio Tana, Lanfranco Pellesi, Eloísa Rubio‐Beltrán, Marta Waliszewska‐Prosół, William Wells-Gatnik, Marco Lisicki, Alberto Raggi, Matteo Castaldo, Gianluca Coppola, Adriana Della Pietra, Xiangning Fan, Parisa Gazerani, Lou Grangeon, Licia Grazzi, Keiko Ihara, Alessia Marcassoli, Danilo Antonio Montisano, Agnese Onofri, Michela Tinelli, S. Vigneri, Doğa Vurallı, Wei Wang
2024-10-31

acute and prophylactic treatmentgenetic and molecular basismigrainemigraine auramigraine heterogeneity
BACKGROUND AND AIM: Migraine is a common disabling conditions which, globally, affects 15.2% of the population. It is the second cause of health loss in terms of years lived with disability, the first among women. Despite being so common, it is poorly recognised and too often undertreated. Specialty centres and neurologists with specific expertise on headache disorders have the knowledge to provide specific care: however, those who do not regularly treat patients with migraine will benefit from a synopsis on the most relevant and updated information about this condition. This paper presents a comprehensive view on the hallmarks of migraine, from genetics and diagnostic markers, up to treatments and societal impact, and reports the elements that identify migraine specific features. MAIN RESULTS: The most relevant hallmark of migraine is that it has common and individual features together. Besides the known clinical manifestations, migraine presentation is heterogeneous with regard to frequency of attacks, presence of aura, response to therapy, associated comorbidities or other symptoms, which likely reflect migraine heterogeneous genetic and molecular basis. The amount of therapies for acute and for prophylactic treatment is really wide, and one of the difficulties is with finding the best treatment for the single patient. In addition to this, patients carry out different daily life activities, and might show lifestyle habits which are not entirely adequate to manage migraine day by day. Education will be more and more important as a strategy of brain health promotion, because this will enable reducing the amount of subjects needing specialty care, thus leaving it to those who require it in reason of refractory condition or presence of comorbidities. CONCLUSIONS: Recognizing the hallmarks of migraine and the features of single patients enables prescribing specific pharmacological and non-pharmacological treatments. Medical research on headaches today particularly suffers from the syndrome of single-disease approach, but it is important to have a cross-sectional and joint vision with other close specialties, in order to treat our patients with a comprehensive approach that a heterogeneous condition like migraine requires.
1
Acute and preventive migraine therapies are numerous, making individualized treatment selection a major clinical challenge.
2
Clinical heterogeneity likely reflects diverse genetic and molecular mechanisms underlying migraine.
3
Migraine affects 15.2% of the global population and is the second leading cause of health loss measured by years lived with disability, ranking first among women.
4
Migraine combines shared core characteristics with substantial individual heterogeneity in attack frequency, aura, treatment response, comorbidities, and associated symptoms.
5
Patient education and brain-health promotion may improve daily migraine management and reduce the need for specialty care, reserving it for refractory or comorbid cases.
6
Recognizing migraine hallmarks alongside patient-specific features supports tailored pharmacological and non-pharmacological treatment.

migraine

the defining hallmarks and heterogeneous clinical, genetic, molecular, diagnostic, therapeutic, and societal features of migraine

Publication Details
Publication Date
2024-10-31
Journal
Publisher
ISSN
Cited by
192
Access Type
Author Information
Authors
Matilde Leonardi
Tissa Wijeratne
Tsubasa Takizawa
Marco A. Arruda
Valeria Caponnetto
Andreas Straube
Massimiliano Valeriani
Mário Fernando Prieto Peres
Paolo Martelletti
Sebastian Straube
Bianca Raffaelli
Kristin Sophie Lange
David García‐Azorín
Yonggang Wang
Fu‐Jung Hsiao
Igor Petrušić
Alejandro Labastida‐Ramírez
Dilara Onan
Claudio Tana
Lanfranco Pellesi
Eloísa Rubio‐Beltrán
Marta Waliszewska‐Prosół
William Wells-Gatnik
Marco Lisicki
Alberto Raggi
Matteo Castaldo
Gianluca Coppola
Adriana Della Pietra
Xiangning Fan
Parisa Gazerani
Lou Grangeon
Licia Grazzi
Keiko Ihara
Alessia Marcassoli
Danilo Antonio Montisano
Agnese Onofri
Michela Tinelli
S. Vigneri
Doğa Vurallı
Wei Wang
Explore further
Open the scid.ai AI chat with a ready-made request: it will find papers on a similar topic and help build a literature review.
Find similar papers in the chat
Make a presentation
100%